Connect with us


Weekly Market Pulse: Rational Optimist

I have often been accused over the years of being too optimistic and I will plead guilty to having a little rose colored tint in my glasses. I am an optimist…



I have often been accused over the years of being too optimistic and I will plead guilty to having a little rose colored tint in my glasses. I am an optimist by nature and I search constantly for good things to write about. There are more than enough people out there willing to tell you the world is coming to an end, in more interesting ways than I could ever imagine. I don’t feel like I can add much to the doom and gloom canon. Besides, the sunny side of the aisle is pretty roomy right now. Come on over. Be an early adopter!

Rose colored my glasses may be but they don’t blind me to the potential problems investors face; I am a rational, realistic optimist. The Fed is going to meet this week and the course of the stock and bond markets, at least for a while, will be determined by what is decided at the FOMC meeting. That is not how this is supposed to work but it is the reality of the situation, at least for now. We should be concentrating on making long term investments that will benefit us, and the economy, instead of worrying about what some central banker might say. But in the age of the loquacious central banker we will instead focus our attention on Jerome Powell. Sigh.

Regardless of what Powell and the others on the FOMC do now, we should all remember that we are here, in this inflationary mess, because of their previous actions. Inflation is a monetary phenomenon and they are the folks in charge of monetary policy. They underestimated, by a wide margin, the price to be paid for financing $7 trillion in fiscal folly. Expecting them to now get things right is the triumph of hope over experience. A mistake now, to try and correct that last one, seems almost assured. The question, as with so many things in economics, is depth, how deep the gash of the economic slowdown. Parson Powell has already told us that we need to feel pain – repent, ye free spending consumers! – if we are to atone for his mistakes. The only question is how much he can inflict before the economy rolls over or the politicians call for his scalp.

I personally think that slowing nominal GDP growth is going to prove challenging. If the Fed’s goal is to kill inflation by pushing the economy into recession they’re going to have to overcome the huge pile of cash they left behind last year. Household and corporate balance sheets are remarkably liquid. Yes, there has been some drawdown in the “excess” savings of the COVID era, but it’s only about a quarter of the total so far. At the current pace, the “excess” will be gone in just 3 short years.

The Fed may be able to scare people sufficiently with an economic slowdown to get them to pull back spending temporarily. But as soon as the economy starts to turn up, they’ll start spending again. And, since the savings rate generally rises during recession, they’ll replenish the pile of “excess” savings.

But right now, the economy is slowing and the Fed is pursuing an aggressive tightening policy. The yield curve is almost entirely flat to inverted, the 3 month T-bill rate joining the rest of the curve, from 6 months to 7 years, in rising above the 10 year rate. The inversion of the 10 year/3 month spread has, in the past, heralded a coming recession. Of course, it tells us nothing about timing; the average lead time from inversion to recession in the last four recessions is 14 months. So, yes we’re on recession watch but we will need confirming signals to take action. We have a few now – LEI down six months in a row for instance – but there are important checkboxes, such as credit spreads, that remain blank.

This isn’t a situation that demands immediate action. The trend of the dollar and interest rates is still up at this point and stocks are, despite this rally, still in a downtrend. An opportunity is likely to arise when one of those big trends changes. If it is because rates start to fall there will be an opportunity in bonds. If it is because the dollar gets in a downtrend the opportunity could be in gold or commodities. Stocks would likely benefit from stability, in rates and the dollar.

I will expect to get emails this week about how I’m a Pollyanna because I have the gall to think of the US economy as, for lack of a better word, resilient. Imagine how negative the mood is if mere resilience is the optimistic view. Frankly, I don’t know how you could view the US economy as anything but resilient. It has taken a lot of abuse over the years, from monetary and fiscal authorities, and it keeps coming back for more. The US economy isn’t resilient because of the Federal Reserve or the Congress or the President. It is in spite of them.


The dollar and the 10 year Treasury yield continued their correction last week. The 10 year yield fell about 20 basis points. The dollar fell to a low of 109.36 (I told you a couple of weeks ago that first downside target was 109; close enough) before recovering slightly on Friday. The dollar index is now down 3.6% from its September high of 114.75. It’s in a short term downtrend for now but the longer term trend is still up.

The dollar is certainly still well loved and for good and obvious reasons but it appears to be peaking on the long term chart. I can’t give a reason for that right now but I guarantee you that when it peaks it will be obvious as hell with the benefit of hindsight. Those good and obvious reasons it is well loved are, by the way, already reflected in today’s price. For now, I’d say the next downside target is around 104.

BTW, the dollar index at 104 is still a strong dollar and would still not violate the long term uptrend.

For rates, the most interesting development last week was the inversion of the 10 year/3 month yield curve – again. When I started writing this it was again uninverted and now it is inverted again. Oh my, what does it mean? Let me be as clear as possible. The inversion of this part of the yield curve is a traditional warning sign for recession. It does not, as best I can tell, cause a recession but it is correlated. I do not believe we have had an inversion of this part of the curve in the post-war period that didn’t eventually lead to recession.

So, the inversion means that the odds of recession sometime in the near future have risen. Does it mean recession is inevitable? No, we could have the first inversion of the post-war period that doesn’t lead to recession. I don’t think that will happen but it certainly could and it wouldn’t surprise me at all. I have said this repeatedly over the last couple of years but this post-COVID period is unique. We don’t have a precedent of recovering from a global pandemic with a massive fiscal response funded via a massive monetary response. We don’t have a precedent for what happens after governments effectively shut down the global economy and then restart it. We sure don’t have a precedent for all those things and a war in the heart of Europe.

Even in the best of circumstances, in a more “normal” economy, the lead time from inversion to recession is widely variable:

The impact on stocks is also variable. Stock market bottoms have happened as soon as 3 months from the onset of recession (1953/54) and as long as 20 months (2001). Stock markets tend to peak before recession but the lead can be as much as a year to none at all. There have been bear markets without recessions (1946, 1961, 1966, 1987) but I don’t know of an instance where we had a recession without a bear market.

What does all that history add up to? Every bear market and every recession is different, the past merely a rough guide to the future. The only prediction I’ll make is that when we get a recession, we will almost certainly have a bear market too. And that if that recession is far enough in the future, we could have a bull market in the interim. The range of possibilities is necessarily wide.


Stocks were up again last week, extending the rally that started on October 13th. From intraday low to the close last Friday, the S&P 500 has risen 11.7%. Small cap stocks are up a little more at 12.7%. REITs have added 11.1% during this fall rally. What’s more interesting is that the rally in risk has occurred without a rally in bonds. During the summer stock market rally, the 10 year yield fell from 3.48% to 2.79% but risk has rallied this time while rates have risen.

Why have stocks put in this rally right before the Fed meeting this week? Earnings have been pretty good with some glaring exceptions like Meta and a few other tech stocks. Industrials, REITs and financials have all performed well which might indicate this rally is more about growth than rates but given the recent yield curve inversion that explanation also feels a bit wanting.

It could also be some investors getting a jump on the mid-term elections, assuming that Republicans will take control of Congress. I have no deep insights to offer on that score except to say that if they do, markets generally seem to like gridlock. It’s almost as if the less the politicians do the better the economy performs. Imagine that.

Whatever the explanation, I think this rally has gone way too far, way too fast. Sentiment has turned bullish very quickly and there appears to be some FOMO going on and not just at the retail level. Institutional investors are likely fretting the rally too knowing that if the market rallies into year end and they miss it, they might be looking for a job next year. Or as Eddie Murphy once put it so pithily, they “ain’t going to have the money to buy their son the GI Joe with the kung fu grip”.

I do not expect Jerome Powell to offer any encouraging words to the bulls this week so if that’s what they’re counting on, I think they’re going to be disappointed. If you’ve been thinking of buying this rally, I’d hold off. And if you’re a trader and bought the bottom you probably want to take some chips off the table. Even if this is a rally that continues, a pullback based on Fed talk, would be healthier than just continuing to go up. I’d say the odds heavily favor at least a correction of the recent uptrend.

This has been primarily a US based rally too and last week was no different. China continued its self immolation after the Xi-fest, down another 9% last week. That non-US stocks still underperformed with the dollar falling last week, means they performed even worse in their own currencies. Can the US avoid recession if the rest of the world succumbs? Well, it is more likely than the reverse but hardly a sure bet.

Value outperformed growth and small stocks outperformed large, two trends that are looking more and more durable.

Financials, real estate and industrials led the way based on good earnings. Utilities were also higher, rebounding from their September drubbing. But defensive stocks also had a good week so maybe there’s more to it than just a little downtick in rates. It is a bit strange to see defensive stocks and economically sensitive stocks rallying together. I suspect it won’t last.

Credit spreads have fallen during the risk on rally too and are now back below 5%. We may be headed for recession but if so, someone should alert the junk bond market.

This week’s commentary is a day late because I was out of town to attend a very special wedding. That’s what got me to thinking about optimism this week. The newlyweds, Marcelo and Alexis, are young, successful and about to start a family. They have managed somehow to be daring and conservative all at once. They are fearless in their travels and adventures but also frugal and conservative, carefully husbanding the capital they’ve worked so hard to accumulate. They are loyal to their families but open and welcoming, always making their guests feel special and included. They are what we hope our future holds.

And, importantly, Marcelo and Alexis are not alone. We are privileged to know many young people (I find that is a much more flexible term as I get older) who allow me, encourage me, inspire me to see a better future. We read a lot about how awful the millennial generation is – narcissistic, unfocused, lazy, entitled winners of participation trophies. But as Jonathan Swift wrote:

Falsehood flies and the truth comes limping after.

The truth, that our future is actually in good hands, is mundane and draws no attention because it has happened repeatedly in our history. And it appears to me that it very much remains true today. Thank you Marcelo and Alexis for doing things your own way, for proving, to me at least, that America’s best days are still ahead of her.


Joe Calhoun

Alhambra’s Resident Optimist

Read More

Continue Reading


Weekly Digest – December 16, 2022

Friday, December 16, 2022Volume 3, Issue 59 Quote of the Week “Remember that you must behave as at a banquet. Is anything brought round to you? Put…



Friday, December 16, 2022
Volume 3, Issue 59

Quote of the Week

“Remember that you must behave as at a banquet. Is anything brought round to you? Put out your hand and take a moderate share. Does it pass by you? Do not stop it. Is it not yet come? Do not yearn in desire toward it, but wait till it reaches you. So with regard to children, wife, office, riches; and you will some time or other be worthy to feast with the gods. And if you do not so much as take the things which are set before you, but are able even to forego them, then you will not only be worthy to feast with the gods, but to rule with them also. For, by thus doing, Diogenes and Heraclitus, and others like them, deservedly became divine, and were so recognized.”

— Epictetus, The Enchiridion, 15

Fortune Cookies

Fortune cookies are entertaining because they come with a vague statement that can often be interpreted positively. But they are usually not to be taken seriously. This is why I find myself annoyed when I read “fortune cookies” on Twitter that provide vapid advice claiming to make inherently difficult things easy to accomplish. 

Since we are approaching the end of the year when many people start thinking about New Year’s resolutions, I thought that I would provide eight (hopefully) higher quality “fortune cookies” of my own that took many years to figure out. 

  • Almost nothing worthwhile can be achieved without considerable effort. If you want something, be prepared to work very hard to get it.
  • If you hate your job, find a different one or switch to a different career. If you are still young, “retirement” is almost certainly a mistake. Find something that you are good at and enjoy doing and then commit to it wholeheartedly. 
  • Commit to reading 25 pages per day. That is over 9,000 pages per year and will put you at the very top in terms of attainment of wisdom, provided that you read with purpose. While difficult at first, it will get easier in time. Eventually, it will be very difficult to not read on a daily basis. Such days will feel incomplete.
  • Start a journal. Writing for fifteen minutes every morning can make a big difference in setting the tone for the day and keeping your goals on track.
  • Avoid hatred at all costsHatred leads to disaster and harms the person doing the hating more than the target of hatred. Instead of falling into hatred, disassociate from toxic people, especially in cases of lies and deception.
  • Be kind to others, especially those who through no fault of their own have been dealt a bad hand. But never allow someone to take advantage of your kindness. Provide a helping hand, not a handout, and never facilitate dysfunctional behavior. Cut people out of your life who are only interested in money.
  • Avoid envy. The people you see on social media who appear to have “perfect lives” almost certainly do not. Many are secretly miserable and hide behind beautiful fictions posted on social media to fool themselves as well as others.
  • Do not confuse frugality with cheapness. Default to generosity when it makes sense. Being cheap when it comes to health and well-being is stupid, and the same is true for intellectual pursuits. Books distill thousands of hours of the author’s time for the cost of a restaurant meal or less. Never budget for books.

These might be “fortune cookies”, but they could actually make a positive impact even though none are necessarily easy to implement. I can say that all of these concepts have helped me despite taking years or, in some cases decades, to really figure out.


Consoles and Competition by Ben Thompson, December 12, 2022. This article provides over forty years of history of the video game industry before analyzing the FTC’s attempt to block Microsoft’s acquisition of Activision. As someone who is not familiar with the intricacies of this case, I found the lengthy discussion of the industry’s history very valuable since it provides necessary context. “For the record, I do believe this acquisition demands careful overview, and it’s completely appropriate to insist that Microsoft continue to deliver Activision titles to other platforms, even if it wouldn’t make economic sense to do anything but. It’s increasingly difficult, though, to grasp any sort of coherent theory to the FTC’s antitrust decisions beyond ‘big tech bad’.” (Stratechery)

Sea Change by Howard Marks, December 13, 2022. In this memo, Howard Marks points out that forty years of declining interest rates represented a major tailwind for investors. He likens falling interest rates to a moving walkway in an airport. Just as moving walkways make life easier for weary travelers, falling interest rates act as an assist for investors. However, this secular decline in interest rates appears to be at an end which represents a sea change in the investment landscape. Investors need to be aware that the strategies that worked well over the past forty years may not lead to outperformance in the future. (Oaktree Capital)

The California Effect by Mr. Money Mustache, December 10, 2022. The cost of living is famously high in the San Francisco Bay Area where Mr. Money Mustache recently spent a few days observing the attitudes of people with very different approaches to spending money. The reality is that even in the most expensive regions, spending excessively is always a choice, not an inevitable mandate. “San Francisco professionals live in a place where 25-year-old tech workers enjoy $200,000 starting salaries, yet still have credit card debt and car loans, and they think that is normal.” (Mr. Money Mustache)

The College Essay Is Dead by Stephen Marche, December 6, 2022. Will artificial intelligence kill the college essay? Anyone who has played with ChatGPT, a new AI tool that recently opened to the public, might be asking the question which this article explores. I admit to being a little baffled about the handwringing. After all, when I was in college three decades ago, we took exams using technology no more advanced than blue books and a pen or pencil. AI might help students cheat on work done outside the classroom, but you cannot fake your way through an exam where there is no technology other than paper and a writing implement. (The Atlantic)

Ideas That Changed My Life by Morgan Housel, December 7, 2022. Among other topics, Morgan Housel makes an excellent case for reading. Otherwise, your personal experiences will excessively influence your perception of how the world works. “Your personal experiences make up maybe 0.00000001% of what’s happened in the world but maybe 80% of how you think the world works. People believe what they’ve seen happen exponentially more than what they read about has happened to other people, if they read about other people at all. We’re all biased to our own personal history.” (Collaborative Fund)

Thankfully, Life Is Full of Problems by Lawrence Yeo, December 7, 2022. I was reminded of Viktor Frankl when I read this article. Frankl held that people gain a sense of purpose not through a tensionless state but by struggling and striving toward a personally meaningful goal. Lawrence Yeo makes a similar case. What we must do is to “upgrade” from dealing with meaningless problems to a focus on addressing “heavyweight” problems. (More to That)

The Gift of Time by Nick Maggiulli, December 13, 2022. Almost everyone thinks about money in terms of goods or services it can buy. But money is really the gift of time: “Because everything I write isn’t really about money, it’s about time. Time with your loved ones. Time to enjoy yourself. Time to live the life you want. In the end, all of your money will be converted back to time anyways. If not now, then later. And if not by you, then by someone else. Possibly after you’re gone.” (Of Dollars and Data)

Be Wary of Imitating High-Status People Who Can Afford to Countersignal by Rob Henderson, December 11, 2022. This article argues that we should avoid emulating people who have achieved status far above ours, and instead look to those who are just somewhat ahead of us. People with very high status can afford to exhibit unusual behavior. For example, a famous author doesn’t need to use Twitter personally to surface his writing because his fans will do this for him. That’s not the case for most authors seeking wider distribution of their work. (Rob Henderson’s Newsletter)

How Neuroscience Confirms the Most Ancient Myths About Music by Ted Gioia, December 12, 2022. Music has a tremendous capacity to influence our lives as listeners, often putting us into flow states conducive to productivity. For example, I often listen to The Dave Brubeck Quartet’s performance at Carnegie Hall in 1963 when I want to get serious work done. For musicians, performing can induce an even deeper flow state, as Ted Gioia describes: “In the midst of an intense performance, the music seemed to be playing itself.” This article on music and neuroscience is part of a book being published in installments on Substack. (The Honest Broker)


Tom Gayner Discusses the Evolution of Markel, December 14, 2022. 56 minutes. This is a wide-ranging interview covering topics including Berkshire Hathaway’s recent investment in Markel, the growth of Markel Ventures in the context of the company’s overall capital allocation strategy, the use of leverage, and how investing during the pandemic was more challenging than the financial crisis. (Boyar Value Group)

The Essays of Warren Buffett, January 20, 2022. 1 hour, 58 minutes. According to Lawrence Cunningham’s newsletter, which you can sign up for here, the sixth edition of his compilation of Warren Buffett’s shareholder letters will be released early next year. I have the first and second editions and highly recommend the book. While all of the letters are available on Berkshire’s website, the compilation is organized by topic and adds significant value. In this podcast, David Senra provides his enthusiastic commentary about what he took away from this book. (Founder’s Podcast)

Master of Precision: Henry Leland Founder of Cadillac, May 31, 2020. 1 hour, 10 minutes. I think Steve Jobs and Henry Leland had much in common in terms of insisting on high quality and viewing their role as craftsmen, paying obsessive attention to details. “There always was and there always will be conflict between Good and Good Enough. In opening up a new business one can count on meeting resistance to a high standard of workmanship. It is easy to get cooperation for mediocre work, but one must sweat blood for a chance to produce a superior product. —Henry Leland” (Founders Podcast)

DoorDash: Looking for Profitable Routes, December 14, 2022. “DoorDash was founded in 2013 by four Stanford students, who saw an opportunity to make it easier for people to get the food they love delivered to them. Today, DoorDash’s three-sided marketplace serves as one of the largest local delivery companies in the world, serving millions of customers and partnering with hundreds of thousands of restaurants across 27 countries, run rating at over $50 billion of gross merchandise value.” (Business Breakdowns)

Twitter Threads

This is a brief thread on the importance of reading. It is based on The Use of Letters, a journal entry I wrote early last year. Why would anyone voluntarily limit their understanding of the world to just their own direct experiences?

Checking quotes frequently is counterproductive. There is too much noise in quotes when checked on a daily basis and doing so is likely to make most investors miserable.

The origin story of the Eiffel Tower:

A Shepherd and His Flock in Winter

From Wikipedia:

Frederick Ferdinand Schafer (August 16, 1839 – July 18, 1927) was a German-born American painter. He was born in Braunschweig, Germany and he emigrated to the United States in 1876, at age 37. 

Schafer’s paintings, which mostly depict landscape scenes in California and other western states, are dated between 1873 and 1911. There are many scenes of Yosemite National Park included in a catalog of his paintings. As the weather turns colder, I thought that this scene of an unknown location captures the season quite well.

A Shepherd and His Flock in Winter, Frederick Ferdinand Schafer (public domain)

Here is a description of this painting by Jerome H. Saltzer, Professor of Computer Science Emeritus at the Massachusetts Institute of Technology:

“This painting might be described as luminist in style. Paintings such as this one may be the basis for the suggestion that Schafer’s later work was lighter, but the shortage of dated paintings makes it difficult to confirm that suggestion.”

Copyright and Disclaimer

Nothing in this newsletter constitutes investment advice and all content is subject to the copyright and disclaimer policy of The Rational Walk LLC.

Your privacy is taken very seriously. No email addresses or any other subscriber information is ever sold or provided to third parties. If you choose to unsubscribe at any time, you will no longer receive any further communications of any kind.

The Rational Walk is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to

Read More

Continue Reading


FDA advisory committee votes unanimously in favor of a one-shot COVID-19 vaccine approach – 5 questions answered

Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine…



The FDA advisory committee discussed vaccine safety, effectiveness of the current shots, potential seasonality of COVID-19 and more. wildpixel/iStock via Getty Images Plus

The U.S. Food and Drug Administration’s key science advisory panel, the Vaccines and Related Biological Products Advisory Committee, met on Jan. 26, 2023, to chart a path forward for COVID-19 vaccine policy. During the all-day meeting, the 21-member committee discussed an array of weighty issues including the efficacy of existing vaccines, the composition of future vaccine strains and the need to match them to the circulating variants of SARS-CoV-2, the possibility of moving to an annual-shot model, the potential seasonality of the virus and much more.

But the key question at hand, and the only formal question that was voted on, following a proposal from the FDA earlier in the week, had to do with how to simplify the path to getting people vaccinated.

The Conversation asked immunologist Matthew Woodruff, who has been on the front lines of studying immune responses to COVID-19 since the early days of the pandemic, to walk us through the big questions of the day and what they mean for future COVID-19 vaccine strategies.

What exactly did the advisory committee vote on?

The question put before the committee for a vote was whether to move to one COVID-19 vaccine consisting of a single composition for all people – whether currently vaccinated or not – and away from the current model that includes one formulation given as a primary series and a separate formulation administered as a booster. Importantly, approved formulations could come from any number of vaccine manufacturers, not just those that have currently authorized vaccines.

The U.S. Centers for Disease Control and Prevention currently requires that the primary series of shots, or the first two doses of the vaccine that a patient receives, consist of the first generation of vaccine against the original strain of SARS-CoV-2, known as the “Wuhan” strain of the virus. These shots are given weeks apart, followed months later by a booster shot that was updated in August 2022 to contain a bivalent formulation of vaccine that targets both the original viral strain and newer subvariants of omicron.

The committee’s endorsement simplifies those recommendations. In a 21-to-0 vote, the advisory board recommended fully replacing, or “harmonizing,” the original formulation of the vaccine with a single shot that would consist of – at least for now – the current bivalent vaccine.

In doing so, it has signaled its belief that these new second-generation vaccines are an upgrade over their predecessors in protecting from infection and severe illness at this point in the pandemic.

If the FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent shot – will be used for both vaccinated and unvaccinated people.

Will the single shot remain a mixed-strain, or bivalent, vaccine?

For now, the single shot will be bivalent. But this may not always be the case.

There was a general agreement that the current bivalent shot is preferable to the original vaccine targeted at the Wuhan strain of the virus by itself. But committee members debated whether that original Wuhan vaccine strain should continue to be a part of updated vaccine formulations.

There is no current data comparing a monovalent, or single-strain, vaccine that targets omicron and its subvariants against the current bivalent shot. As a result, it’s unclear how a monovalent shot against recent omicron subvariants would perform in comparison to the bivalent version.

What is immune imprinting, and how does it apply here?

A main reason for the debate over monovalent versus bivalent – or, for that matter, trivalent or tetravalent – vaccines is a lack of understanding around how best to sharpen an immune response to a slightly altered threat. This has long been a debate surrounding annual influenza vaccination strategies, where studies have shown that the immune “memory” that forms in response to a prior vaccine can actively repress a robust immune response to the next.

This phenomenon of immune imprinting, originally coined in 1960 as “original antigenic sin,” has been a topic of debate both within the advisory committee and within the broader immunological community.

Although innovative strategies are being developed to overcome potential problems with routinely updated vaccines, they are not yet ready to be tested in humans. In the meantime, it is unclear how bivalent versus monovalent vaccine choices might alter this phenomenon, and it is very clear that more study is needed.

Is the committee considering only mRNA vaccines?

While a significant portion of the discussion focused on the mRNA vaccine platform used by both Pfizer and Moderna, several committee members emphasized the need for new technologies that could provide broader immunological protection. Dr. Pamela McInnes, a now-retired longtime deputy director of the National Center for Advancing Translational Sciences, highlighted this point, saying, “I would make a plea for ongoing research on broader protection, maybe different platforms, maybe a different approach.”

A good deal of attention was also directed toward Novavax, a protein-based formulation that relies on a more traditional approach to vaccination than the mRNA-based vaccines. Although the Novavax vaccine has been authorized by the FDA for use since July 2022, it has received much less national attention – largely because of its latecomer status. Nonetheless, Novavax has boasted efficacy rates on par with its mRNA cousins, with good safety profiles and less demanding long-term storage requirements than the mRNA shots.

By simplifying the vaccine schedule to include only a single vaccine formulation, the committee reasoned, it might be easier for competing vaccination platforms to break into the market. In other words, newer vaccine contenders would not have to rely on patients’ having already received their primary series before using their products. Companies seemed ready to take advantage of that future flexibility, with researchers from Pfizer, Moderna and Novavax all revealing their companies’ exploration of a hybrid COVID-19 and flu shot at various stages of clinical trials and testing.

Would the single shot resemble flu vaccine development?

Not necessarily. Currently, the influenza vaccine is decided by committee through the World Health Organization. Because of its seasonal nature, the strains to be included in each season’s flu vaccine strain for the Southern and Northern hemispheres, with their opposing winters, are selected independently. The Northern Hemisphere’s selection is made in February for the following winter based on a vast network of flu monitoring stations around the globe.

Although there was broad consensus among panelists that the shots against SARS-CoV-2 should be updated regularly to more closely match the most current circulating viral strain, there was less agreement on how frequent that would be.

For instance, rapidly mutating strains of the virus in both summer and winter surges might necessitate two updated shots a year instead of just one. As Dr. Eric Rubin, an infectious disease expert from the Harvard T.H. Chan School of Public Health, noted, “It’s hard to say that it’s going to be annual at this point.”

Matthew Woodruff receives funding from the National Institute of Health and the US Department of Defense to support his academic research.

Read More

Continue Reading

Spread & Containment

Measles virus ‘cooperates’ with itself to cause fatal encephalitis

Fukuoka, Japan—Researchers in Japan have uncovered the mechanism for how the measles virus can cause subacute sclerosing panencephalitis, or SSPE, a…



Fukuoka, Japan—Researchers in Japan have uncovered the mechanism for how the measles virus can cause subacute sclerosing panencephalitis, or SSPE, a rare but fatal neurological disorder that can occur several years after a measles infection.

Credit: Kyushu University/Hidetaka Harada/Yuta Shirogane

Fukuoka, Japan—Researchers in Japan have uncovered the mechanism for how the measles virus can cause subacute sclerosing panencephalitis, or SSPE, a rare but fatal neurological disorder that can occur several years after a measles infection.

Although the normal form of the measles virus cannot infect the nervous system, the team found that viruses that persist in the body can develop mutations in a key protein that controls how they infect cells. The mutated proteins can interact with its normal form, making it capable of infecting the brain. Their findings were reported in the journal Science Advances.

If you are of a certain age, you may have gotten the measles as a child. Many born after the 1970s have never gotten it thanks to vaccines. The condition is caused by the virus of the same name, which is one of the most contagious pathogens to this day. The World Health Organization estimates that nearly nine million people worldwide were infected with measles in 2021, with the number of deaths reaching 128,000.

“Despite its availability, the recent COVID-19 pandemic has set back vaccinations, especially in the Global South,” explains Yuta Shirogane, Assistant Professor at Kyushu University’s Faculty of Medical Sciences. “SSPE is a rare but fatal condition caused by the measles virus. However, the normal measles virus does not have the ability to propagate in the brain, and thus it is unclear how it causes encephalitis.”

A virus infects cells through a series of proteins that protrude from its surface. Usually, one protein will first facilitate the virus to attach to a cell’s surface, then another surface protein will cause a reaction that lets the virus into the cell, leading to an infection. Therefore, what a virus can or cannot infect can depend heavily on the type of cell.

“Usually, the measles virus only infects your immune and epithelial cells, causing the fever and rash,” continues Shirogane. “Therefore, in patients with SSPE, the measles virus must have remained in their body and mutated, then gained the ability to infect nerve cells. RNA viruses like measles mutate and evolve at very high rates, but the mechanism of how it evolved to infect neurons has been a mystery.”

The key player in allowing the measles virus to infect a cell is a protein called fusion protein, or F protein. In the team’s previous studies, they showed that certain mutations in the F protein puts it in a ‘hyperfusongenic’ state, allowing it to fuse onto neural synapses and infect the brain.

In their latest study, the team analyzed the genome of the measles virus from SSPE patients and found that various mutations had accumulated in their F protein. Interestingly, certain mutations would increase infection activity while others actually decreased it.

“This was surprising to see, but we found an explanation. When the virus infects a neuron, it infects it through ‘en bloc transmission,’ where multiple copies of the viral genome enter the cell,” continues Shirogane. “In this case, the genome encoding the mutant F protein is transmitted simultaneously with the genome of the normal F protein, and both proteins are likely to coexist in the infected cell.”

Based on this hypothesis, the team analyzed the fusion activity of mutant F proteins when normal F proteins were present. Their results showed that fusion activity of a mutant F protein is suppressed due to interference from the normal F proteins, but that interference is overcome by the accumulation of mutations in the F protein.

In another case, the team found that a different set of mutations in the F protein results in a completely opposite result: a reduction in fusion activity. However, to their surprise, this mutation can actually cooperate with normal F proteins to increase fusion activity. Thus, even mutant F proteins that appear to be unable to infect neurons can still infect the brain.

“It is almost counter to the ‘survival of the fittest’ model for viral propagation. In fact, this phenomenon where mutations interfere and/or cooperate with each other is called ‘Sociovirology.’ It’s still a new concept, but viruses have been observed to interact with each other like a group. It’s an exciting prospect” explains Shirogane.

The team hopes that their results will help develop therapeutics for SSPE, as well as elucidate the evolutionary mechanisms common to viruses that have similar infection mechanisms to measles such as novel coronaviruses and herpesviruses.

“There are many mysteries in the mechanisms by which viruses cause diseases. Since I was a medical student, I was interested in how the measles virus caused SSPE. I am happy that we were able to elucidate the mechanism of this disease,” concludes Shirogane.


For more information about this research, see “Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus” Yuta Shirogane, Hidetaka Harada, Yuichi Hirai, Ryuichi Takemoto, Tateki Suzuki, Takao Hashiguchi, Yusuke Yanagi,

About Kyushu University
Kyushu University is one of Japan’s leading research-oriented institutes of higher education since its founding in 1911. Home to around 19,000 students and 8,000 faculty and staff, Kyushu U’s world-class research centers cover a wide range of study areas and research fields, from the humanities and arts to engineering and medical sciences. Its multiple campuses—including the largest in Japan—are located around Fukuoka City, a coastal metropolis on the southwestern Japanese island of Kyushu that is frequently ranked among the world’s most livable cities and historically known as a gateway to Asia.

Read More

Continue Reading